SCHEMBL3322256

SCHEMBL3322256

COc1ccc(-c2ccc3c(C(=O)O)cccc3c2)c(C23CC4CC(CC(C4)C2)C3)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.48
RARB P10826 5/20 0.48
RARG P13631 5/20 0.48
MEN1 O00255 4/20 0.48
RARA P10276 3/20 0.48
LMNA P02545 2/20 0.48
NR1I2 O75469 1/20 0.48
PGR P06401 1/20 0.48
HSPD1 P10809 1/20 0.48
GOT1 P17174 1/20 0.48
GLRA1 P23415 1/20 0.48
BLM P54132 1/20 0.48
HSPE1 P61604 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
THRB P10828 1/20 0.43
RECQL P46063 1/20 0.43
NR2E1 Q9Y466 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3347374 0.91 SLC6A3 (0.44) KMT2ARARBRARGMEN1RARA
SCHEMBL3322258 0.82 RARB (0.67) KMT2ARARBRARGMEN1RARA
SCHEMBL9300831 0.82 RARB (0.69) KMT2ARARBRARGMEN1RARA
SCHEMBL3350681 0.80 SLC6A3 (0.42) KMT2ARARBRARGMEN1RARA
SCHEMBL29222875 0.80 WDR5 (0.45) KMT2ARARBRARGMEN1RARA
SCHEMBL6571522 0.79 RARB (0.54) KMT2ARARBRARGMEN1RARA
SCHEMBL6878528 0.77 KMT2A (0.51) KMT2ARARBRARGMEN1RARA
SCHEMBL5613344 0.76 PPARG (0.44) KMT2ARARBRARGMEN1RARA
SCHEMBL6535850 0.75 CDC25B (0.55) KMT2AMEN1LMNANR1I2SMN1; SMN2
SCHEMBL9078624 0.75 KMT2A (0.47) KMT2ARARBRARGMEN1RARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896399-B1 BIPHENYL AND NAPHTHYL-PHENYL HYDROXAMIC ACID DERIVATIVES SIGMA TAU IND FARMACEUTI (IT) 2010-11-17 EP disclosed
US-7728039-B2 Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2010-06-01 US disclosed
US-20080319082-A1 Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-12-25 US disclosed
EP-1896399-A1 BIPHENYL AND NAPHTHYL-PHENYL HYDROXAMIC ACID DERIVATIVES SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. (IT) 2008-03-12 EP disclosed
WO-2007000383-A1 BIPHENYL AND NAPHTHYL-PHENYL HYDROXAMIC ACID DERIVATIVES SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2007-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319082-A1 Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives VHL, ARNT, AHR KMT2A 606/4885RARB 136/4885RARG 246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.